Home › Open-Angle Glaucoma › NCT07400926

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Diagnosis of Open-angle glaucoma
* 18 years of age or older

Exclusion Criteria:

* Subject who is breast-feeding or pregnant

About the study

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

What is being tested

• Travoprost (combination product)

Sponsor: Glaukos Corporation · Participants: 30 · Started: Dec 17, 2025

Contact the study team

• Study Director · Phone: 949-739-8749

Official record on ClinicalTrials.gov — NCT07400926

Locations in the U.S.

Conditions

• Open-Angle Glaucoma
• Ocular Hypertension
• Glaucoma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.